In specimens of human Stage I prostate cancers, 0.1% of cells expressed prostate cancer stem/progenitor-like cell markers, including CD44, CD133, CK5/14 and integrin α2β1 [18], [19]. The gene discussed is KRT5; the disease is prostate carcinoma.